Evaluation of analgesic interaction between morphine, dexmedetomidine and maropitant using hot-plate and tail-flick tests in rats

Vet Anaesth Analg. 2019 Jul;46(4):476-482. doi: 10.1016/j.vaa.2018.12.009. Epub 2019 Apr 8.

Abstract

Objective: To determine if the combinations of morphine, dexmedetomidine and maropitant enhance the analgesic effect and decrease the dose of individual drugs in rats subjected to noxious thermal stimulation with hot-plate and tail-flick tests.

Study design: Randomized, blinded, prospective experimental study.

Animals: A total of 96 male Sprague-Dawley rats.

Methods: The rats were randomly assigned to the following groups: 1) morphine (3 mg kg-1; Mor); 2) dexmedetomidine (10 μg kg-1; Dex); 3) maropitant (20 mg kg-1; Maro); 4) morphine (1.5 mg kg-1) + dexmedetomidine (5 μg kg-1; Mor + Dex); 5) dexmedetomidine (5 μg kg-1) + maropitant (10 mg kg-1; Dex + Maro); 6) morphine (1.5 mg kg-1) + maropitant (10 mg kg-1; Mor + Maro); 7) morphine (1 mg kg-1) + dexmedetomidine (3.5 μg kg-1) + maropitant (6.5 mg kg-1; Mor + Dex + Maro); and 8) normal saline (0.5 mL; saline), all injected intravenously. The tail-flick and hot-plate tests were performed before and 5, 15, 30, 45, 60, 90 and 120 minutes after the injection of the drugs. These variables were analysed with the effect-time area under the curve (AUC) analysis and a mixed linear model.

Results: Data were analysed in 94 rats. The rank order of the total analgesic effects of the treatment groups shown by AUC analysis was found to be Mor > Maro + Mor > Dex + Mor > Dex > Maro > Dex + Maro + Mor > Dex + Maro > saline for the hot-plate test, and Maro + Mor > Mor > Dex + Mor > Dex + Maro + Mor > Maro > Dex > Dex + Maro > saline for the tail-flick test. The mixed model analysis showed a significant difference between latencies of the group morphine + maropitant versus all other treatment groups in the tail-flick test (p < 0.0001) and morphine versus saline in the hot-plate test (p < 0.05).

Conclusions and clinical relevance: Morphine and maropitant appeared to show a supra-additive effect for analgesia in the tail-flick test. Clinical trials should be conducted to establish its use in treating pain.

Keywords: analgesia; combination; dexmedetomidine; maropitant; morphine; rat model.

MeSH terms

  • Analgesics, Non-Narcotic / administration & dosage
  • Analgesics, Non-Narcotic / pharmacology
  • Analgesics, Opioid / administration & dosage
  • Analgesics, Opioid / pharmacology
  • Animals
  • Antiemetics / administration & dosage
  • Antiemetics / pharmacology
  • Dexmedetomidine / administration & dosage
  • Dexmedetomidine / pharmacokinetics
  • Dexmedetomidine / pharmacology*
  • Drug Synergism
  • Drug Therapy, Combination
  • Male
  • Morphine / administration & dosage
  • Morphine / pharmacokinetics
  • Morphine / pharmacology*
  • Pain / drug therapy*
  • Pain Measurement / veterinary*
  • Quinuclidines / administration & dosage
  • Quinuclidines / pharmacokinetics
  • Quinuclidines / pharmacology*
  • Random Allocation
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Analgesics, Non-Narcotic
  • Analgesics, Opioid
  • Antiemetics
  • Quinuclidines
  • maropitant
  • Dexmedetomidine
  • Morphine